Is Ozempic safe if I have chronic kidney disease?

For many people with chronic kidney disease it is not only safe but beneficial. The FLOW trial randomised people with type 2 diabetes and chronic kidney disease to semaglutide or placebo and found a 24% reduction in major kidney events, alongside cardiovascular benefit. The caution is short-term rather than long-term: reduced kidney reserve means dehydration from vomiting or diarrhea is less well tolerated, so sick-day planning matters more than it does for other people.

Do GLP-1s need a dose adjustment for kidney disease?

The labelling for semaglutide and tirzepatide does not require dose adjustment on the basis of renal impairment, including in severe impairment, because these drugs are not primarily cleared by the kidney. That is different from saying no additional care is needed. Experience in people on dialysis is limited, monitoring of kidney function during titration is sensible, and the medications you take alongside frequently do need adjusting as weight and blood pressure fall.

Can a GLP-1 damage your kidneys?

Not directly, in the ordinary course. Acute kidney injury does appear in the prescribing information, and the pathway is dehydration: vomiting or diarrhea, plus not drinking enough, plus commonly a diuretic, ACE inhibitor, ARB or SGLT2 inhibitor that was entirely appropriate before. That combination is how an avoidable injury happens, and it is largely preventable with fluid and by holding the right medications during an illness. Report inability to keep fluids down for 24 hours or reduced urine output the same day.

My eGFR fell after starting. Should I worry?

It depends on the size, the timing and what else changed. A small dip after starting a medication that changes fluid balance can settle, and it is worth repeating rather than reacting to. Two specific confounders are worth ruling out first: dehydration at the time of the test, and creatine supplementation, which raises serum creatinine by roughly 0.1–0.3 mg/dL without harming the kidney and therefore lowers calculated eGFR. Tell whoever ordered the test if either applies.

The Research

Comorbidities

GLP-1s and Kidney Disease

Two opposite things are true at once: these drugs protect the kidney over years, and they can injure it in a single bad week. Both belong in the same conversation and they almost never get one.

Elise Hall, MDJanuary 13, 20264 min read

This is a topic where the reassuring long-term story and the genuine short-term hazard get separated, usually into different conversations with different people, and the result is patients who are either needlessly frightened or insufficiently careful.

Both halves belong together.

The long-term story is good

The FLOW trial, published in the NEJM in 2024, randomised people with type 2 diabetes and chronic kidney disease to semaglutide or placebo. It reported a 24% reduction in major kidney events — a composite including kidney failure, substantial loss of kidney function, and death from kidney or cardiovascular causes. The trial was stopped early for efficacy.

That sits alongside cardiovascular outcome data in overlapping populations, discussed in the heart data. For a person with type 2 diabetes and chronic kidney disease, this is not a drug being tolerated despite kidney disease. It is increasingly a drug being used for it.

Worth being precise about the population, though: FLOW studied people with type 2 diabetes and CKD. Extrapolating the kidney benefit to someone without diabetes taking a GLP-1 purely for weight is reasonable in direction and not established in size.

The short-term hazard is real and preventable

Acute kidney injury appears in the prescribing information, and the route to it is entirely mundane.

Vomiting or diarrhea → reduced circulating volume → reduced kidney perfusion → injury. Add reduced fluid intake, because thirst cues quieten and about a fifth of daily water normally arrives inside food you are no longer eating. Then add the medication list.

These are the agents that turn a bad week into a kidney problem, and almost everyone in this population takes at least one:

Medication	Why it matters when you are dehydrated
Diuretics	Actively deplete volume further
ACE inhibitors / ARBs	Reduce the kidney’s ability to protect its own filtration pressure
SGLT2 inhibitors	Add volume loss; also euglycemic DKA risk when unwell
NSAIDs	Constrict the afferent arteriole; avoid entirely during illness

None of those were wrong when they were prescribed. They become a problem in a specific 48-hour window.

The plan you want is agreed in advance, not improvised on the day: which of these you hold when you cannot keep fluids down, and when to call. Most prescribers hold the first three routinely during a dehydrating illness. Ask yours what your rules are before you need them — that is the whole point of sick day rules.

What monitoring is worth doing

Before starting: kidney function and electrolytes, particularly if you have known CKD, diabetes, or take any of the medications above.

During titration: a repeat is reasonable, especially after any illness, and especially in older adults where reserve is lower — see taking a GLP-1 after 65.

After any episode of significant vomiting or diarrhea: worth checking, and worth mentioning even if you feel fine again.

Two confounders that make results look worse than they are

Dehydration at the time of the test. A blood test taken during or just after a bad week reflects that week. Repeat before concluding anything.

Creatine. This one causes genuine confusion. Creatine supplementation raises serum creatinine by roughly 0.1–0.3 mg/dL — because creatinine is the breakdown product of creatine, not because anything is wrong. eGFR is calculated from creatinine, so the calculated number falls and a panel that used to read 95 comes back 85.

In someone with healthy kidneys this is a measurement artefact with a long safety literature behind it. It is also exactly the sort of thing that gets misread on a drug where clinicians are alert to kidney trouble. Say you take it before anyone interprets the panel, and if a genuine question remains, stopping it for 2 weeks before a repeat settles it. The detail is in the creatine rankings.

If you already have significant kidney disease, creatine is a conversation with your prescriber rather than a shelf decision — as is magnesium, which is renally cleared and accumulates in CKD.

Dosing, briefly

Neither semaglutide nor tirzepatide requires dose adjustment on the basis of renal impairment, including severe impairment. These are not renally cleared drugs, so the pharmacokinetics do not change much.

What that does not mean:

Experience in people on dialysis is limited, and that is a specialist decision.
The other drugs you take frequently do need adjusting, particularly sulfonylureas and insulin as intake falls, and antihypertensives as weight falls.
Titrating slowly is more valuable here than in most people, because the thing you are trying to avoid is a week of vomiting.

The practical summary

If you have kidney disease and type 2 diabetes, the evidence increasingly supports these drugs rather than merely permitting them. The thing that will hurt you is not the drug over years; it is a stomach bug over 48 hours with a diuretic still on board.

So: know your baseline numbers, agree your sick-day plan before you need it, keep oral rehydration sachets in the cupboard for the reasons in the electrolytes piece, and call early rather than late. Cannot keep fluids down for 24 hours, or passing much less urine than usual, is a same-day call — not something to sleep on.

Questions I get about this month

Is Ozempic safe if I have chronic kidney disease?: For many people with chronic kidney disease it is not only safe but beneficial. The FLOW trial randomised people with type 2 diabetes and chronic kidney disease to semaglutide or placebo and found a 24% reduction in major kidney events, alongside cardiovascular benefit. The caution is short-term rather than long-term: reduced kidney reserve means dehydration from vomiting or diarrhea is less well tolerated, so sick-day planning matters more than it does for other people.
Do GLP-1s need a dose adjustment for kidney disease?: The labelling for semaglutide and tirzepatide does not require dose adjustment on the basis of renal impairment, including in severe impairment, because these drugs are not primarily cleared by the kidney. That is different from saying no additional care is needed. Experience in people on dialysis is limited, monitoring of kidney function during titration is sensible, and the medications you take alongside frequently do need adjusting as weight and blood pressure fall.
Can a GLP-1 damage your kidneys?: Not directly, in the ordinary course. Acute kidney injury does appear in the prescribing information, and the pathway is dehydration: vomiting or diarrhea, plus not drinking enough, plus commonly a diuretic, ACE inhibitor, ARB or SGLT2 inhibitor that was entirely appropriate before. That combination is how an avoidable injury happens, and it is largely preventable with fluid and by holding the right medications during an illness. Report inability to keep fluids down for 24 hours or reduced urine output the same day.
My eGFR fell after starting. Should I worry?: It depends on the size, the timing and what else changed. A small dip after starting a medication that changes fluid balance can settle, and it is worth repeating rather than reacting to. Two specific confounders are worth ruling out first: dehydration at the time of the test, and creatine supplementation, which raises serum creatinine by roughly 0.1–0.3 mg/dL without harming the kidney and therefore lowers calculated eGFR. Tell whoever ordered the test if either applies.

Sources

Written by

Elise Hall, MD

Board-certified internist in Los Angeles, twenty-one years in practice. She writes about GLP-1 medications and metabolic health for people who want the reasoning, not just the conclusion — and publishes her own year on one of these drugs alongside it.

More about Dr. Hall Get the Sunday letter

Keep reading

Supplements

The Best Supplements for GLP-1 Hair Loss

The shedding starts two to four months after the loss speeds up, which is why almost nobody connects the two. Seven supplements ranked — and one of them interferes with the blood test that rules out a heart attack.

Sep 20268 min

Supplements

Best Bone Health Supplements on a GLP-1

Bone is the tissue nobody thinks about until a wrist breaks. Rapid weight loss reduces bone mineral density, the effect is largest in exactly the people most likely to be prescribed these drugs, and none of it produces a symptom until it does.

Sep 20267 min

Tools

The Best GLP-1 Apps, Ranked

I scored every tracker I could get my hands on against seven criteria that matter specifically on a GLP-1 — not generic calorie counting. Here is the ranking, the rubric behind it, and where my first choice falls short.

Aug 202610 min